Sarcosine

Sarcosine

SCHEMBL7363936

CC1(C)C2CCC1(CS(=O)(=O)NCC(=O)O)C(=O)C2.CNCC(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
CYP1A2 P05177 1/20 0.57
CYP2C19 P33261 1/20 0.57
CA1 P00915 6/20 0.53
CA2 P00918 6/20 0.53
CA5A P35218 6/20 0.53
CA5B Q9Y2D0 6/20 0.53
F2 P00734 2/20 0.53
PRSS1 P07477 2/20 0.53
PRSS2 P07478 2/20 0.53
PRSS3 P35030 2/20 0.53
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7362007 0.95 ALDH1A1 (0.63) ALDH1A1CYP1A2CYP2C19CA1CA2
Sarcosine SCHEMBL7364548 0.83 ITGB3 (0.50) ALDH1A1CYP1A2CYP2C19CA1CA2
Arginine SCHEMBL7360830 0.83 CYP1A2 (0.43) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL18118973 0.80 ALDH1A1 (0.72) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL27566680 0.79 ALDH1A1 (0.60) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL16503505 0.78 ALDH1A1 (0.74) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL24146497 0.78 ALDH1A1 (0.66) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL27656329 0.77 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL25434270 0.77 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C19CA1CA2
SCHEMBL27792104 0.77 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2C19CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6025472-A PEPTIDE ALDEHYDES WHICH ARE POTENT INHIBITORS OF FACTOR XA, USEFUL AS THERAPEUTIC AGENTS FOR DISEASE STATES IN MAMMALS CHARACTERIZED BY ABNORMAL THROMBOSIS CORVAS INTERNATIONAL, INC. (US) 2000-02-15 US disclosed
US-5696231-A ANTICOAGULANTS; CARDIOVASCULAR DISORDERS CORVAS INTERNATIONAL, INC. (US) 1997-12-09 US disclosed
EP-0801654-A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa CORVAS INTERNATIONAL, INC. (US) 1997-10-22 EP disclosed
WO-1996019493-A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa CORVAS INTERNATIONAL, INC. (US) 1996-06-27 WO disclosed